Astrana Health, Inc. Announces Appointment of Interim National Medical Director

Rhea-AI Summary

Astrana Health (NASDAQ: ASTH) appointed George Christides, M.D. as Interim National Medical Director, effective May 12, 2026. He will oversee population health, care management, and care navigation initiatives across Astrana’s national platform.

Dr. Christides brings 20+ years of clinical and healthcare leadership experience in value-based care and managed care operations.

News Market Reaction – ASTH

+1.92%

1 alert

+1.92% Session close to close

-6.0% Trough Tracked

$2.22B Market Cap

0.7x Rel. Volume

In the May 13 session, ASTH gained 1.92%, reflecting a mild positive market reaction. Argus tracked a trough of -6.0% from its starting point during tracking.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

ALHAMBRA, Calif., May 12, 2026 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a physician-centric, technology-enabled healthcare company empowering providers to deliver accessible, high-quality, and high-value care to all, today announced the appointment of George Christides, M.D. as Interim National Medical Director.

In this role, Dr. Christides will lead the Company's population health, care management, and care navigation initiatives across its national platform.

Dr. Christides is an accomplished healthcare executive with more than 20 years of clinical and healthcare leadership experience across value-based care, population health, and managed care operations. Most recently, he served as Senior Medical Director, Population Health at Astrana, where he led clinical and population health initiatives across the organization.

Prior to joining Astrana, Dr. Christides served as Senior Medical Director at Optum and as Chief Medical Officer at AppleCare Medical Management, where he held leadership roles focused on clinical strategy, care quality, and value-based care delivery.

Dr. Christides earned his B.S. in Cell and Molecular Biology from University of California, Los Angeles and his medical degree from Penn State College of Medicine. He completed his residency in internal medicine at University of Southern California and also holds an MBA from West Texas A&M University.

About Astrana Health, Inc.

Astrana Health is a physician-centric, AI-powered healthcare company committed to delivering high-quality, patient-centered care. Built from the physician's perspective, Astrana combines its scalable care delivery infrastructure, proprietary technology platform, and aligned provider networks to enable proactive, preventive care at scale - improving patient outcomes, enhancing patient experiences, supporting provider well-being, and driving greater value across the healthcare system.

Today, Astrana supports more than 20,000 providers and approximately 1.55 million patients in value-based care arrangements through its affiliated provider networks, management services organization, and integrated care delivery clinics spanning primary, specialty, and ancillary care. Together, Astrana is building the healthcare system we all deserve - one that delivers better care, better experiences, and better outcomes for all. For more information, visit www.astranahealth.com.

Contact:
Carolyne Sohn, Investor Relations
investors@astranahealth.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/astrana-health-inc-announces-appointment-of-interim-national-medical-director-302770024.html

SOURCE Astrana Health, Inc.

FAQ

Who is the new Interim National Medical Director at Astrana Health (NASDAQ: ASTH)?

Astrana Health appointed George Christides, M.D. as Interim National Medical Director. According to Astrana, he is an experienced healthcare executive with more than 20 years in clinical leadership, value-based care, population health, and managed care operations.

What will George Christides, M.D. oversee in his role at Astrana Health (ASTH)?

As Interim National Medical Director, Dr. Christides will lead Astrana’s population health, care management, and care navigation initiatives. According to Astrana, this leadership spans the company’s national platform and supports its physician-centric, technology-enabled care model.

What experience does George Christides bring to Astrana Health (ASTH)?

Dr. Christides brings over 20 years of clinical and healthcare leadership experience. According to Astrana, his background includes value-based care, population health, and managed care operations in roles at Astrana, Optum, and AppleCare Medical Management.

What were George Christides’ previous roles before becoming Interim National Medical Director at Astrana (ASTH)?

Before this appointment, Dr. Christides served as Senior Medical Director, Population Health at Astrana. According to Astrana, he previously held Senior Medical Director at Optum and Chief Medical Officer at AppleCare Medical Management, focusing on clinical strategy and care quality.

What is the educational background of Astrana Health’s Interim National Medical Director?

Dr. Christides holds a B.S. in Cell and Molecular Biology from UCLA and an M.D. from Penn State College of Medicine. According to Astrana, he completed internal medicine residency at USC and also earned an MBA from West Texas A&M University.